The Role of Haptic Technology in the Development of Aesthetic Driven Products

Author(s):  
Monica Bordegoni ◽  
Umberto Cugini

This paper presents a haptic system the authors have developed for shape exploration in the field of industrial design. The system consists of a novel haptic-based digital technology, allowing designers to add the tactile experience to the visual one. The haptic interface developed allows designers to see and haptically feel through free hand motions an object surface during its creation and evolution. The system closes the loop of shape modification and its subsequent evaluation: It is possible to evaluate the “what if” related to a new product shape, applying the modification and comparing the solutions more and more times, and generate and maintain different versions. That improves the level of interaction of designers with the digital models, exploits their skills, and shortens the product development life cycle.

2015 ◽  
Vol 66 (1) ◽  
pp. 114-118
Author(s):  
Aleksandar Miltenović ◽  
Milan Banić ◽  
Vojislav Miltenović

Abstract Product development is a creative task where is systematically created a new product, which makes possible to firms to offer attractive, innovative and market oriented products. In conditions of fierce competition and saturated markets, companies that do not innovate are stagnating and disappear from the market. Innovation is therefore every intervention which can reduce production costs, enables optimum utilization of available human, energy and material resources, improve product quality, improve the placement, which leads to an increase in competitiveness. A prerequisite for fulfillment of the above-mentioned tasks is that the companies have engineers with the appropriate competencies, which are able to, through creativity, innovation and fascinating technique of creating new or improving existing products and lunch it on the market. The paper discusses the role and importance of the competences that are necessary for a successful professional career of product development engineers.


2010 ◽  
Vol 27 (3-4) ◽  
pp. 172-182 ◽  
Author(s):  
Effrosyni Petala ◽  
Renee Wever ◽  
Chris Dutilh ◽  
Han Brezet

2018 ◽  
Vol 43 (4) ◽  
pp. 517-543 ◽  
Author(s):  
Ruggero Sainaghi ◽  
Manuela De Carlo ◽  
Francesca d’Angella

This article aims to identify the key elements underlying a destination capability (DC) and to examine what the genesis of these factors is and how they interact to foster the destination development. The article explores a specific development process—the creation of a new product in an alpine destination (Livigno, Italy)—making use of a theoretical framework structured around four major dimensions: DCs, coordination at the destination level, inter-destination bridge ties, and destination development. The results help clarify the genesis of a DC in the context of new product development. First, the dynamics underlying the creation of a DC show that coordination at the destination level constitutes the heart of the process, whereas the integration of scattered resources in the new product plays a more limited role. Second, from a dynamic perspective, the analysis has identified three patterns (scouting, implementation, and involvement).


2002 ◽  
Vol 44 (4) ◽  
pp. 1-23
Author(s):  
David Luery ◽  
David Hanlon

Pricing research has an important role to play in the go/no-go decisions taken to finance the progress of new drugs in development. There is a hierarchy in decision-making when it comes to determining the price of new drugs. Many different audiences (government, HMOs/insurance companies, formulary committees, physicians and patients) play a role in determining the price of new drugs. The questions then are when should we start pricing research, who should we talk to and what techniques should be used? This paper explores the role of pricing research throughout the eight- to ten-year development life cycle of new drugs. We examine the various pricing research approaches tailored to suit the different decision-marking audiences at the appropriate milestones in assessing the clinical and commercial potential of new drugs.


Sign in / Sign up

Export Citation Format

Share Document